UK's MHRA approves GSL switch for Acnecide

24 September 2019 - Deborah Wilkes

Archived

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two medicines containing benzoyl peroxide – Galderma's Acnecide Face Gel and Acnecide Face Wash – to be switched from pharmacy (P) to general-sale list (GSL) status.

Click tags below for more information on topics:

Nestlé MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: